Sanofi News

Sanofi has announced the availability of an additional 250,000 doses of its influenza vaccine in response to rising demand and vaccine shortages, particularly in Île-de-France. Charles Wolf, the director for Sanofi in France, emphasized the company's commitment to addressing the situation by providing these extra doses, which were initially intended for the European market. The decision comes as the flu season intensifies, leading to increased concerns about vaccine accessibility.